Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.
D000818:Animals; D002784:Cholesterol / Q000097:blood; D003864:Depression, Chemical; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified / Q000097:blood* / Q000378:metabolism; D005990:Glycerol / Q000097:blood*; D006400:Hematocrit; D006949:Hyperlipidemias / Q000139:chemically induced; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood*
D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D014280:Triglycerides; D002784:Cholesterol; D011433:Propranolol; D005990:Glycerol; D009638:Norepinephrine